Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/20/2014 | US8728397 Substance detection device utilizing a cyclone particle separator |
05/20/2014 | US8728396 Sample analyzer and sample transporting method |
05/20/2014 | US8728299 Biosensor performance increasing methods having enhanced stability and hematocrit performance |
05/20/2014 | US8728297 Small volume in vitro analyte sensor |
05/20/2014 | US8726719 Light-weight analyzer for odor recognition |
05/20/2014 | US8726718 Payout-glide-flakeoff apparatus for characterizing deodorant and antiperspirant sticks |
05/20/2014 | DE202014003013U1 Messgerät Gauge |
05/20/2014 | CA2812312A1 Device, method, system and kit for the detection of contaminants and/or pathogens in consumables by way of a color-change analysis using nanoparticles within a hydrogel |
05/20/2014 | CA2723031C Polypeptides having neutrophil stimulating activity |
05/20/2014 | CA2709605C Sampling and evaluation of subterranean formation fluid |
05/20/2014 | CA2655460C Methods and materials for observing apoptosis |
05/20/2014 | CA2597044C 5-fluoro-uracil immunoassay |
05/20/2014 | CA2563074C Gene expression markers for predicting response to chemotherapy |
05/20/2014 | CA2557103C System and method for the spectroscopic determination of the components and concentrations of pumpable organic compounds |
05/20/2014 | CA2529882C Cell line and uses thereof |
05/20/2014 | CA2471504C Ligand for g-protein coupled receptor gpr43 and uses thereof |
05/20/2014 | CA2448567C Modulators of nucleic acid ligands |
05/20/2014 | CA2364160C Product and method for treatment of conditions associated with receptor-desensitization |
05/15/2014 | WO2014075098A1 Methods and kits for diagnosing sjögren's syndrome |
05/15/2014 | WO2014075096A1 Inhibitors of central nervous system vasoactive inhibitory peptide receptor 2 |
05/15/2014 | WO2014075083A1 Methods for predicting age and identifying agents that induce or inhibit premature aging |
05/15/2014 | WO2014075016A1 Electrophoretic bar code assay devices and methods for making and using the same |
05/15/2014 | WO2014074922A1 Concentrating a target molecule for sensing by a nanopore |
05/15/2014 | WO2014074907A1 C-met-specific capture agents, compositions, and methods of using and making |
05/15/2014 | WO2014074887A1 Methods of and systems for improved detection sensitivity of assays |
05/15/2014 | WO2014074847A1 A genetic assay to determine prognosis in polycythemia vera patients |
05/15/2014 | WO2014074835A2 Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone |
05/15/2014 | WO2014074821A1 Metabolic profiling in tissue and serum is indicative of tumor differentiation in prostate cancer |
05/15/2014 | WO2014074773A1 Self-contained assay device |
05/15/2014 | WO2014074762A1 Method of increased throughput in an immunoassay analyzer |
05/15/2014 | WO2014074737A1 Methods and devices for processing samples and counting cells |
05/15/2014 | WO2014074729A1 Collagen iv binding assay for the detection of collagen vii |
05/15/2014 | WO2014074727A1 Nucleic acid sequencing using tags |
05/15/2014 | WO2014074720A1 Efficient modulated imaging |
05/15/2014 | WO2014074701A1 Ionization of chemicals in mixture at low ph by ambient ionization / mass spectrometry |
05/15/2014 | WO2014074682A1 Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
05/15/2014 | WO2014074569A1 System and method for serum based cancer detection |
05/15/2014 | WO2014074322A1 Devices and methods for nucleic acid extraction capture and concentration using electric fields and centrifugation |
05/15/2014 | WO2014074277A1 Preparatory high performance liquid chromatographic (hplc) separation technique for quantitative fractionation of heavy petroleum streams |
05/15/2014 | WO2014074054A1 Sulphur content indicator for fuel, vehicle comprising such an indicator and a method for indicating sulphur content in fuel |
05/15/2014 | WO2014074020A1 Method for printing biological ligands in the biochip manufacturing process |
05/15/2014 | WO2014074004A1 Method for determining the flow rates of the constituents of a multi-phase mixture |
05/15/2014 | WO2014074002A1 Method and system for the detection of metal inclusions in molten slag |
05/15/2014 | WO2014073985A1 A method and system for automated differential irrigation |
05/15/2014 | WO2014073885A1 Standard protein complex for quantitative analysis of multimers of multimer-forming polypeptides |
05/15/2014 | WO2014073767A1 Chamber apparatus for product pollutant discharge experiments |
05/15/2014 | WO2014073708A1 Novel peptide and use thereof |
05/15/2014 | WO2014073653A1 Method for testing for nephritis-lesion sites and reagent therefor |
05/15/2014 | WO2014073529A1 MEDICINE COMPRISING MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL ASSOCIATED WITH ALLERGIC DISEASE, CD300a GENE KNOCK-OUT MOUSE, AND USE OF MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL |
05/15/2014 | WO2014073464A1 Peptide and antibody test material for detecting both vivax malaria and falciparum malaria |
05/15/2014 | WO2014072753A1 Personal test device |
05/15/2014 | WO2014072545A1 Method and kit for determining inorganic polyphosphates in blood plasma |
05/15/2014 | WO2014072537A1 Use of quality indicators for checking thawing processes in frozen sample tissues |
05/15/2014 | WO2014072526A1 Development of hbv- and/or hdv-susceptible cells, cell lines and non-human animals |
05/15/2014 | WO2014072524A1 Lipopetides for use in treating liver diseases and cardiovascular diseases |
05/15/2014 | WO2014072500A1 Tnt based diagnosis of paroxysmal atrial fibrillation |
05/15/2014 | WO2014072492A2 Phosphorescent dye and phosphorescence immunoassay by peptide displacement |
05/15/2014 | WO2014072471A1 Ntprobnp and ctnt based therapy guidance in heart failure |
05/15/2014 | WO2014072467A1 Method for prediction of an immune response against mismatched human leukocyte antigens |
05/15/2014 | WO2014072465A1 In vitro capture and analysis of circulating tumor cells |
05/15/2014 | WO2014072416A1 Methods and pharmaceutical compositions for the treatment of bone metastases |
05/15/2014 | WO2014072370A1 Test strip ejector for medical device |
05/15/2014 | WO2014072313A1 Peptides that can be used in coating agents, adhesion promoters or adhesives for oxidic surfaces |
05/15/2014 | WO2014072086A1 Biomarkers for prognosis of lung cancer |
05/15/2014 | WO2014071973A1 Method and kit for determination of free copper in serum |
05/15/2014 | WO2014071642A1 Microfluidic chip for capturing cells and preparing method thereof |
05/15/2014 | WO2014071503A1 Identification of the dcps gene on 11q24.2, which encodes the human decapping enzyme scavenger, in non-syndromic autosomal recessive mental retardation, diagnostic probes thereof and methods of identifying subjects with same |
05/15/2014 | WO2014071456A1 Diagnostic, prognostic, therapeutic and screening protocols |
05/15/2014 | WO2014071455A1 Diagnostic, prognostic, therapeutic and screening protocols with respect to infectious mycobacterium |
05/15/2014 | WO2014038682A3 Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells |
05/15/2014 | WO2014023957A3 Anti-tumour response to modified self-epitopes |
05/15/2014 | WO2014015194A3 Methods for detecting and measuring aggregation |
05/15/2014 | WO2014009280A3 Cooking control device, cooking control system and computer program product |
05/15/2014 | WO2013153461A3 Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases |
05/15/2014 | WO2013149258A8 Compositions and methods for treating or preventing metabolic syndrome disorders |
05/15/2014 | WO2013048644A3 Device and method for detection and quantification of immunological proteins, pathogenic and microbial agents and cells |
05/15/2014 | WO2013044261A3 Mrm/srm assay for death receptor 5 protein |
05/15/2014 | WO2013039477A8 Non-invasive methods of detecting target molecules |
05/15/2014 | WO2013028807A3 Renal cell carcinoma biomarkers and uses thereof |
05/15/2014 | WO2013025467A3 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
05/15/2014 | US20140137274 Induced malignant stem cells |
05/15/2014 | US20140136136 Nox detection apparatus and nox sensor system |
05/15/2014 | US20140135808 System for withdrawing blood |
05/15/2014 | US20140135487 Immunostimulatory g, u-containing oligoribonucleotides |
05/15/2014 | US20140135384 Endogenous retrovirus polypeptides linked to oncogenic transformation |
05/15/2014 | US20140135327 N- (2 -aminophenyl) benzamide derivatives as histone deacetylase inhibitors |
05/15/2014 | US20140135302 Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
05/15/2014 | US20140135296 Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits |
05/15/2014 | US20140135260 Ghrelin Analogs |
05/15/2014 | US20140135255 Peptidomimetic macrocycles |
05/15/2014 | US20140135236 Matrix for receiving a tissue sample and use thereof |
05/15/2014 | US20140135235 Glycan and glycopeptide capture and release using reversible hydrazone-based method |
05/15/2014 | US20140135232 Methods and materials for determining the efficacy of prostate cancer therapies |
05/15/2014 | US20140135230 Lipoparticles Comprising Proteins, Methods Of Making, And Using The Same |
05/15/2014 | US20140135227 Use of periostin as a novel biomarker |
05/15/2014 | US20140135226 Display library process |
05/15/2014 | US20140135224 Quantitative diagnostic methods using multiple parameters |
05/15/2014 | US20140134753 Methods for treating transthyretin amyloid diseases |
05/15/2014 | US20140134752 Method for specific identification of target biomolecules |
05/15/2014 | US20140134751 Diagnostic method |